2018年美国西班牙裔/拉丁裔人群癌症统计
美国癌症协会每3年发布西班牙裔/拉丁裔人群癌症统计,基于NCI、NAACCR和CDC数据。2018年预计新发149,100例、死亡42,700例;整体发病和死亡率低于非西班牙裔白人,但感染相关癌症(如肝癌)可达其2倍。汇总数据掩盖异质性,波多黎各前列腺癌发病率和死亡率显著高于其他美国西班牙裔。
要点
- 西班牙裔整体癌症发病低25%、死亡低30%,但感染相关癌症负担更高。
- 波多黎各前列腺癌发病率146.6/10万,高于其他美国西班牙裔和非西班牙裔白人。
- 需针对西班牙裔亚群开展文化适应性干预和专项监测研究。
核心结论
- 西班牙裔整体癌症负担低于非西班牙裔白人,但感染相关癌症负担更高且亚群异质性显著。
研究设计与样本
- 美国癌症协会基于NCI、NAACCR和CDC数据每3年发布的西班牙裔癌症统计报告。
主要发现
- 2018年美国本土和夏威夷预计西班牙裔新发癌症149,100例、癌症死亡42,700例。
- 西班牙裔所有癌症合计发病比非西班牙裔白人低25%,死亡低30%。
- 西班牙裔感染相关癌症(如肝癌)发病率可达非西班牙裔白人的2倍。
- 2011-2015年波多黎各前列腺癌发病率为146.6/10万,比其他美国西班牙裔合计(91.6/10万)高60%,比非西班牙裔白人(101.7/10万)高44%。
- 2011-2015年前列腺癌是波多黎各男性首位癌症死因,占近1/6癌症死亡;其他美国西班牙裔男性首位死因为肺癌。
关键数值与推荐
- 西班牙裔所有癌症合计发病比非西班牙裔白人低25%,死亡低30%。
- 波多黎各前列腺癌发病率146.6/10万,其他美国西班牙裔合计91.6/10万,非西班牙裔白人101.7/10万。
- 2011-2015年波多黎各前列腺癌死亡占男性癌症死亡近1/6。
临床怎么用
- 应关注西班牙裔亚群差异,针对波多黎各等亚群加强前列腺癌防控和监测。
- 需开展文化适应性干预以提高预防服务利用并降低癌症风险因素流行。
- 应增加波多黎各特异性及亚群特异性癌症研究和监测经费。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cancer is the leading cause of death among Hispanics/Latinos, who represent the largest racial/ethnic minority group in the United States, accounting for 17.8% (57.5 million) of the total population in the continental United States and Hawaii in 2016. In addition, more than 3 million Hispanic Americans live in the US territory of Puerto Rico. Every 3 years, the American Cancer Society reports on cancer occurrence, risk factors, and screening for Hispanics in the United States based on data from the National Cancer Institute, the North American Association of Central Cancer Registries, and the Centers for Disease Control and Prevention. For the first time, contemporary incidence and mortality rates for Puerto Rico, which has a 99% Hispanic population, are also presented. An estimated 149,100 new cancer cases and 42,700 cancer deaths will occur among Hispanics in the continental United States and Hawaii in 2018. For all cancers combined, Hispanics have 25% lower incidence and 30% lower mortality compared with non-Hispanic whites, although rates of infection-related cancers, such as liver, are up to twice as high in Hispanics. However, these aggregated data mask substantial heterogeneity within the Hispanic population because of variable cancer risk, as exemplified by the substantial differences in the cancer burden between island Puerto Ricans and other US Hispanics. For example, during 2011 to 2015, prostate cancer incidence rates in Puerto Rico (146.6 per 100,000) were 60% higher than those in other US Hispanics combined (91.6 per 100,000) and 44% higher than those in non-Hispanic whites (101.7 per 100,000). Prostate cancer is also the leading cause of cancer death among men in Puerto Rico, accounting for nearly 1 in 6 cancer deaths during 2011-2015, whereas lung cancer is the leading cause of cancer death among other US Hispanic men combined. Variations in cancer risk are driven by differences in exposure to cancer-causing infectious agents and behavioral risk factors as well as the prevalence of screening. Strategies for reducing cancer risk in Hispanic populations include targeted, culturally appropriate interventions for increasing the uptake of preventive services and reducing cancer risk factor prevalence, as well as additional funding for Puerto Rico-specific and subgroup-specific cancer research and surveillance.
引用
- Miller KD, Goding Sauer A, Ortiz AP, et al. Cancer Statistics for Hispanics/Latinos, 2018. CA Cancer J Clin. 2018. PMID: 30285281. doi:10.3322/caac.21494
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。